Katarina Bremme

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: THROMBOSIS RESEARCH. 2021;207:143-149
Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism
Tchaikovski SN; Thomassen MCLGD; Stickeler E; Bremme K; Rosing J
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2021;100(7):1273-1279
The impact of cardiovascular diseases on maternal deaths in the Nordic countries
Nyflot LT; Johansen M; Mulic-Lutvica A; Gissler M; Bodker B; Bremme K; Ellingsen L; Vangen S
Article: LUPUS. 2021;30(7):1031-1038
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus
Bremme K; Honkanen S; Gunnarsson I; Chaireti R
Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2021;34(10):1641-1644
Obstetric and neonatal outcomes in pregnant women treated with high-dose thromboprophylaxis: a retrospective, single-center study
Bremme K; Lannemyr A; Tyni L; Chaireti R
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(2):194-202
Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block
Ivanchenko M; Thorlacius GE; Hedlund M; Ottosson V; Meneghel L; Bjorkander S; Ossoinak A; Tingstrom J; Bremme K; Sverremark-Ekstrom E; Gemzell-Danielsson K; Sonesson S-E; Chemin K; Wahren-Herlenius M
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2582-2589
Management and outcomes of newborns at risk for inherited antithrombin deficiency
Chaireti R; Tronnhagen I; Bremme K; Ranta S
Article: SCIENTIFIC REPORTS. 2020;10(1):13645
Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
Olausson N; Mobarrez F; Zubarev R; Chernobrovkin A; Rutishauser D; Bremme K; Westerlund E; Hovatta O; Wallen H; Henriksson P
Article: LAKARTIDNINGEN. 2020;117:FSWT
[Program for clinical care of immune thrombocytopenic purpura in pregnancy].
Wegnelius G; Bremme K; Lindqvist P
Article: LUPUS. 2019;28(7):868-877
Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile
Hogden A; Antovic A; Berg E; Bremme K; Chaireti R
Article: PLOS ONE. 2019;14(1):e0210544
Blood inflammatory and endothelial markers in women with von Willebrand disease
Govorov I; Bremme K; Larsson A; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: SCIENTIFIC REPORTS. 2018;8(1):17467
Thrombin generation during a regular menstrual cycle in women with von Willebrand disease
Govorov I; Bremme K; Lindahl TL; Holmstrom M; Komlichenko E; Chaireti R; Mints M
Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2018;80(1):e12969
Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack
Vinnars M-T; Bjork E; Nagaev I; Ottander U; Bremme K; Holmlund U; Sverremark-Ekstrom E; Mincheva-Nilsson L
Article: JOURNAL OF HYPERTENSION. 2018;36(4):857-866
Cardiac function, myocardial mechano-energetic efficiency, and ventricular-arterial coupling in normal pregnancy
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Ostlund E; Kahan T
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2018;51(3):361-367
Pregnancy-associated plasma protein-A is positively correlated with first-trimester skin microvascular reactivity
Iacobaeus C; Kahan T; Jorneskog G; Bremme K; Andolf E; Thorsell M
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2018;29(2):141-147
Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practice
Wegnelius G; Bremme K; Lindqvist PG
Article: THROMBOSIS RESEARCH. 2017;158:168-173
Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)
Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmstrom M; Agren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2016;48(4):483-490
Fetal growth is associated with first-trimester maternal vascular function
Iacobaeus C; Kahan T; Jorneskog G; Bremme K; Thorsell M; Andolf E
Article: EXPERIMENTAL AND THERAPEUTIC MEDICINE. 2016;11(5):1923-1929
Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease
Govorov I; Ekelund L; Chaireti R; Elfvinge P; Holmstrom M; Bremme K; Mints M
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2016;76(3):190-194
Inflammatory and endothelial markers during the menstrual cycle
Chaireti R; Lindahl TL; Bystrom B; Bremme K; Larsson A
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2016;10(4):297-306
Cardiac structure and function, and ventricular-arterial interaction 11 years following a pregnancy with preeclampsia
Al-Nashi M; Eriksson MJ; Ostlund E; Bremme K; Kahan T
Article: PLOS ONE. 2016;11(10):e0164683
Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
Govorov I; Lofgren S; Chaireti R; Holmstrom M; Bremme K; Mints M
Article: REPRODUCTIVE BIOMEDICINE ONLINE. 2014;29(6):737-744
Association between trefoil factor 3 gene variants and idiopathic recurrent spontaneous abortion
Haroun S; Altmae S; Karypidis H; Kuningas M; Landgren B-M; Akerud H; Skjoldebrand-Sparre L; Hosseini F; Bremme K; Sundstrom-Poromaa I; Stavreus-Evers A
Article: THROMBOSIS RESEARCH. 2014;134(5):1032-1037
Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
Tchaikovski SN; Thomassen MCLGD; Costa SD; Bremme K; Rosing J
Article: THROMBOSIS RESEARCH. 2014;134(4):837-845
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
Kjellberg U; van Rooijen M; Bremme K; Hellgren M
Article: THROMBOSIS AND HAEMOSTASIS. 2014;112(4):727-735
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity
Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Meroni PL
Article: REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY. 2014;12:70
The histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study
Elenis E; Lindgren KE; Karypidis H; Skalkidou A; Hosseini F; Bremme K; Landgren B-M; Skjoldebrand-Sparre L; Stavreus-Evers A; Sundstrom-Poromaa I; Akerud H
Article: THROMBOSIS RESEARCH. 2014;133(5):936-944
Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome
Vikerfors A; Svenungsson E; Agren A; Mobarrez F; Bremme K; Holmstrom M; Eelde A; Bruzelius M; Elgue G; Wallen H; Antovic A
Article: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE. 2014;27(4):328-332
Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis
Hakansson S; Kaellen K; Bullarbo M; Holmgren P-A; Bremme K; Larsson A; Norman M; Noren H; Ortmark-Wrede C; Pettersson K; Saltvedt S; Sondell B; Tokarska M; von Vultee A; Jacobsson B
Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2014;71(2):178-188
Pre-Eclampsia Affects Cord Blood NK Cell Expression of Activation Receptors and Serum Cytokine Levels but Not CB Monocyte Characteristics
Sohlberg E; Saghafian-Hedengren S; Bachmayer N; Hamad RR; Bremme K; Holmlund U
Article: HYPERTENSION RESEARCH. 2013;36(12):1081-1087
Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia
Ostlund E; Al-Nashi M; Hamad RR; Larsson A; Eriksson M; Bremme K; Kahan T
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2013;92(8):974-977
Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage
Lindgren KE; Karehed K; Karypidis H; Hosseini F; Bremme K; Landgren B-M; Skjoldebrand-Sparre L; Stavreus-Evers A; Sundstrom-Poromaa I; Akerud H
Article: HUMAN REPRODUCTION. 2013;28(7):1846-1852
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
Chaireti R; Gustafsson KM; Bystrom B; Bremme K; Lindahl TL
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2013;24(5):547-553
Obesity and thrombin-generation profiles in women with venous thromboembolism
Sonnevi K; Tchaikovski SN; Holmstrom M; Antovic JP; Bremme K; Rosing J; Larfars G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2013;77(3):200-212
Peripheral Monocyte Expression of the Chemokine Receptors CCR2, CCR5 and CXCR3 is Altered at Parturition in Healthy Women and in Women with Systemic Lupus Erythematosus
Bjorkander S; Heidari-Hamedani G; Bremme K; Gunnarsson I; Holmlund U
Article: BMC MEDICAL GENETICS. 2012;13:121
Phosphodiesterase 8B gene polymorphism in women with recurrent miscarriage: A retrospective case control study
Granfors M; Karypidis H; Hosseini F; Skjoldebrand-Sparre L; Stavreus-Evers A; Bremme K; Landgren B-M; Sundstrom-Poromaa I; Wikstrom A-K; Akerud H
Article: THROMBOSIS RESEARCH. 2012;130(4):636-639
The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives
Bremme K; Hamad RR; Berg E; Strandberg K; Stenflo J
Article: THROMBOSIS RESEARCH. 2012;130(4):596-601
Risk factors for venous thromboembolism in pre- and postmenopausal women
Bergendal A; Bremme K; Hedenmalm K; Larfars G; Odeberg J; Persson I; Sundstrom A; Kieler H
Article: CYTOKINE. 2012;59(2):392-399
Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus
Bjorkander S; Bremme K; Persson J-O; van Vollenhoven RF; Sverremark-Ekstrom E; Holmlund U
Article: LUPUS. 2012;21(7):802-805
Studies of microparticles in patients with the antiphospholipid syndrome (APS)
Vikerfors A; Mobarrez F; Bremme K; Holmstrom M; Agren A; Eelde A; Bruzelius M; Antovic A; Wallen H; Svenungsson E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2012;91(1):50-56
Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia
Hamad RR; Eriksson MJ; Berg E; Larsson A; Bremme K
Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(5):901-907
Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years
Sonnevi K; Tchaikovski SN; Holmstrom M; Rosing J; Bremme K; Larfars G
Article: LAKARTIDNINGEN. 2011;108(34):1564-1568
[Hereditary antithrombin deficiency--rare, but serious. Great risk of venous thromboembolism].
Bremme K; Petrini P; Sallamba M; Tengborn L
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2011;90(6):648-653
Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism
Lindqvist PG; Bremme K; Hellgren M
Article: IMMUNOLOGY. 2011;133(1):41-50
Cord blood monocyte subsets are similar to adult and show potent peptidoglycan-stimulated cytokine responses
Sohlberg E; Saghafian-Hedengren S; Bremme K; Sverremark-Ekstrom E
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2010;29(10):1195-1201
Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program
Granlund M; Axemo P; Bremme K; Bryngelsson A-L; Wallin MC; Ekstrom C-M; Hakansson S; Jacobsson B; Kallen K; Spetz E; Tessin I
Article: THROMBOSIS RESEARCH. 2010;126(2):107-112
Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy
Torkzad MR; Bremme K; Hellgren M; Eriksson MJ; Hagman A; Jorgensen T; Lund K; Sandgren G; Blomqvist L; Kalebo P
Article: ALLERGY. 2010;65(7):822-830
Maternal allergic disease does not affect the phenotype of T and B cells or the immune response to allergens in neonates
Rindsjo E; Joerink M; Johansson C; Bremme K; Malmstrom V; Scheynius A
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2009;34(5):543-549
Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance
Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson S-E
Article: JOURNAL OF HYPERTENSION. 2009;27(11):2257-2264
Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers
Hamad RR; Larsson A; Pernow J; Bremme K; Eriksson MJ
Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2009;62(3):147-157
Women with Pre-Eclampsia Have an Altered NKG2A and NKG2C Receptor Expression on Peripheral Blood Natural Killer Cells
Bachmayer N; Sohlberg E; Sundstrom Y; Hamad RR; Berg L; Bremme K; Sverremark-Ekstrom E
Article: LUPUS. 2009;18(9):792-798
Serologic follow-up of children born to mothers with Ro/SSA autoantibodies
Klauninger R; Skog A; Horvath L; Winqvist O; Edner A; Bremme K; Sonesson SE; Wahren-Herlenius M
Article: THROMBOSIS RESEARCH. 2009;123(4):580-586
Increased thrombin generation in women with a history of preeclampsia
Hamad RR; Curvers J; Berntorp E; Eriksson MJ; Bremme K
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2009;69(2):204-208
Increased levels of an apoptotic product in the sera from women with pre-eclampsia
Hamad RR; Bremme K; Kallner A; Sten-Linder M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2008;154(1):30-37
Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block
Strandberg L; Winqvist O; Sonesson S-E; Mohseni S; Salomonsson S; Bremme K; Buyon JP; Julkunen H; Wahren-Herlenius M
Article: PEDIATRICS. 2008;121(4):e803-e809
Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA Autoantibodies
Skog A; Wahren-Herlenius M; Sundstrom B; Bremme K; Sonesson S-E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2008;87(1):50-58
Group B streptococcal carriage in Sweden:: a national study on risk factors for mother and infant colonisation
Hakansson S; Axemo P; Bremme K; Bryngelsson A-L; Wallin MC; Ekstrom C-M; Granlund M; Jacobsson B; Kallen K; Spetz E; Tessin I
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2008;87(11):1202-1212
The Stockholm classification of stillbirth
Varli IH; Petersson K; Bottinga R; Bremme K; Hofsjo A; Holm M; Holste C; Kublickas M; Norman M; Pilo C; Roos N; Sundberg A; Wolff K; Papadogiannakis N
Article: THROMBOSIS AND HAEMOSTASIS. 2007;98(6):1246-1251
APC resistance during the normal menstrual cycle
van Rooijen M; Silveira A; Thomassen S; Odeberg J; Hamsten A; Rosing J; Bremme K
Article: JOURNAL OF HYPERTENSION. 2007;25(11):2301-2307
Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy
Hamad RR; Eriksson MJ; Silveira A; Hamsten A; Bremme K
Article: IMMUNOLOGY. 2007;122(3):430-437
The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta
Holmlund U; Wahamaa H; Bachmayer N; Bremme K; Sverremark-Ekstrom E; Palmblad K
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2007;5(4):855-858
Preanalytical conditions that affect coagulation testing, including hormonal status and therapy
Blomback M; Konkle BA; Manco-Johnson MJ; Bremme K; Hellgren M; Kaaja R
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2007;86(8):957-962
Erythropoietin and intravenous iron therapy in postpartum anaemia
Wagstrom E; Akesson A; Van Rooijen M; Larson B; Bremme K
Article: THROMBOSIS AND HAEMOSTASIS. 2007;97(1):15-20
Rapid activation of haemostasis after hormonal emergency contraception
von Rooijen M; Silveira A; Thomassen S; Hansson L-O; Rosing J; Hamsten A; Bremme K
Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2006;56(5-6):292-301
Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia
Bachmayer N; Hamad RR; Liszka L; Bremme K; Sverremark-Ekstrom E
Article: LUPUS. 2006;15(6):346-353
Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies
Strandberg L; Salomonsson S; Bremme K; Sonesson S-E; Wahren-Herlenius M
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2006;4(1):77-82
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response
van Rooijen M; Hansson LO; Frostegård J; Silveira A; Hamsten A; Bremme K
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2005;84(10):1018-1019
Low molecular mass heparin (LMMH) for management of thromboembolic disease in pregnancy
van Rooijen M; Bryngelsson AL; Bremme K
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2005;115(6):1304-1310
Neonatal immune responses to microbial stimuli:: Is there an influence of maternal allergy?
Amoudruz P; Holmlund U; Malmström V; Trollmo C; Bremme K; Scheynius A; Sverremark-Ekström E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2004;83(11):1049-1055
Bone turnover from early pregnancy to postweaning
Åkesson A; Vahter M; Berglund M; Eklöf T; Bremme K; Bjellerup P
Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(4):1253-1261
Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2004;190(2):332-337
Sex hormone-binding globulin-A surrogate marker for the prothrombotic effects of combined oral contraceptives
van Rooijen M; Silveira A; Hamsten A; Bremme K
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2003;1(12):2531-2535
Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance
Antovic A; Blombäck M; Bremme K; Van Rooijen M; He S
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003;189(2):568-573
Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion
Frostegård J; Wramsby ML; Wu R; Bremme K
Article: FERTILITY AND STERILITY. 2002;78(6):1172-1177
Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women
Hall G; Blombäck M; Landgren BM; Bremme K
Article: THROMBOSIS AND HAEMOSTASIS. 2002;88(4):644-647
Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
Antovic JP; Hamad RR; Antovic A; Blombäck M; Bremme K
Article: IMMUNOLOGY. 2002;107(1):145-151
Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta
Holmlund U; Cebers G; Dahlfors AR; Sandstedt B; Bremme K; Ekström ES; Scheynius A
Article: ARTHRITIS & RHEUMATOLOGY. 2002;46(5):1233-1241
A serologic marker for fetal risk of congenital heart block
Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2002;81(4):284-292
Diagnostic evaluation of intrauterine fetal deaths in Stockholm 1998-99
Petersson K; Bremme K; Bottinga R; Hofsjö A; Hulthén-Varli I; Kublickas M; Norman M; Papadogiannakis N; Wånggren K; Wolff K
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2002;13(3):181-186
The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism
Antovic A; Blombäck M; Bremme K; He S
Article: LAKARTIDNINGEN. 2002;99(9):899-903
[Cooperation reduces the risks of thyroid disease in pregnancy. Also mild maternal hypothyroidism can threaten the neurological development of the fetus].
Janson A; Alm J; Bremme K; Skjöldebrand-Sparre L; Söder O; Werner S
Article: AMERICAN JOURNAL OF PUBLIC HEALTH. 2002;92(2):284-287
Cadmium exposure in pregnancy and lactation in relation to iron status
Åkesson A; Berglund M; Schütz A; Bjellerup P; Bremme K; Vahter M
Article: OBSTETRICS AND GYNECOLOGY. 2002;99(2):260-266
Soluble transferrin receptor:: Longitudinal assessment from pregnancy to postlactation
Åkesson A; Bjellerup P; Berglund M; Bremme K; Vahter M
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2002;186(1):44-48
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII
van Rooijen M; von Schoultz B; Silveira A; Hamsten A; Bremme K
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2001;12(8):677-681
Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol
He S; Bremme K; Silveira A; van Rooijen M; Blombäck M
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2001;80(9):873-874
A family history can display a synergistic effect of atherogenic and prothrombotic risk in pregnancy
van Rooijen M; Bremme K
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2001;80(6):559-562
Preoperative treatment of anemic women with epoetin beta
Larson B; Bremme K; Clyne N; Nordström L
Article: THROMBOSIS AND HAEMOSTASIS. 2001;85(4):614-618
Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation
Wramsby ML; Bremme K; Blombäck M
Article: PLACENTA. 2001;22(4):372-379
Presence of CD30⁺ and CD30L⁺ cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy
Ekström ES; Bengtsson Å; Svensson A; Nilsson C; Östlund E; Sandstedt B; Bremme K; Lilja G; Scheynius A
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2001;12(2):149-155
Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy
Bremme K; van Rooijen M; Yu A; Blombäck M
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2001;45(2):258-260
Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension
Olofsson C; Bremme K; Forssell G; Öhqvist G
Article: HYPERTENSION IN PREGNANCY. 2001;20(1):79-87
Fibronectin is a marker for organ involvement and may reflect the severity of preeclampsia
Östlund E; Hansson LO; Bremme K
Article: FERTILITY AND STERILITY. 2000;74(5):987-991
Primary habitual abortions are associated with high frequency of Factor V Leiden mutation
Wramsby ML; Sten-Linder M; Bremme K
Article: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2000;9(3):277-281
Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy
He S; Wramsby M; Bokarewa M; Blombäck M; Bremme K
Article: CLINICAL BIOCHEMISTRY. 2000;33(2):131-138
Toxic and essential elements in placentas of Swedish women
Osman K; Åkesson A; Berglund M; Bremme K; Schütz A; Ask K; Vahter M
Article: THROMBOSIS RESEARCH. 1999;96(2):145-156
A laboratory method for determination of overall haemostatic potential in plasma.: I.: Method design and preliminary results
He S; Bremme K; Blombäck M
Article: THROMBOSIS AND HAEMOSTASIS. 1999;81(4):538-542
Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia
He S; Silveira A; Hamsten A; Blombäck M; Bremme K
Article: TRANSFUSION. 1999;39(1):26-31
Clinical evaluation of a solid-phase test for red cell antibody screening of pregnant women
Shanwell A; Sallander S; Bremme K; Westgren M
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 1998;68(6):1241-1246
Serum transferrin receptor:: a specific marker of iron deficiency in pregnancy
Åkesson A; Bjellerup P; Berglund M; Bremme K; Vahter M
Article: HUMAN REPRODUCTION. 1998;13(9):2633-2635
Reactivity against phospholipids during pregnancy
Bokarewa MI; Wramsby M; Bremme K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1998;61(1):21-26
Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor V
Bokarewa MI; Bremme K
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1998;9(4):343-350
A pharmacokinetic study of dalteparin (Fragmin®) during late pregnancy
Blombäck M; Bremme K; Hellgren M; Lindberg H
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 1998;77(2):165-169
Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications
Ostlund E; Bremme K; Wiman B
Article: HYPERTENSION IN PREGNANCY. 1998;17(3):251-263
Blood pressure monitoring in women with previous diagnosis of preeclampsia: The influence of the menstrual cycle
Hjertberg R; Tersman Z; Eneroth P; Bremme K
Article: HYPERTENSION IN PREGNANCY. 1998;17(2):217-226
Fibrin D-dimer levels in preeclamptic pregnancies with birth of small-for-gestational-age neonates
He S; Bremme K; Blombäck M
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1998;9(1):1-9
Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy -: a longitudinal safety study
Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1997;8(4):239-244
Variability of the response to activated protein C during normal pregnancy
Bokarewa MI; Wramsby M; Bremme K; Blomback M
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1997;8(4):232-238
Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia
He S; Bremme K; Blomback M
Article: THROMBOSIS AND HAEMOSTASIS. 1997;77(5):901-904
Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation
Andersson O; Blomback M; Bremme K; Wramsby H
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1997;27(4):340-345
Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance
Bokarewa MI; Falk G; Bremme K; Blomback M; Wiman B
Article: TRANSFUSION. 1996;36(6):500-505
Flow cytometric quantitation of serum anti-D in pregnancy
Christensson M; Bremme K; Shanwell A; Westgren M; Christensson B
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(2):473-478
Arg(506)-Gln mutation in factor V and risk of thrombosis during pregnancy
Bokarewa MI; Bremme K; Blomback M
Article: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 1996;41(1):20-26
Hemostatic abnormalities may predict chronic hypertension after preeclampsia
Bremme K; Blomback M
Article: HYPERTENSION IN PREGNANCY. 1996;15(2):171-182
Decrease in plasminogen activator inhibitor type 2 related more to placental function and intrauterine fetal growth than to severity of preeclampsia
He S; Bremme K; Almqvist I; Blomback M
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1995;6(8):703-708
Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia
He S; Bremme K; Blomback M
Article: TRANSLATIONAL RESEARCH. 1995;126(3):294-298
THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION
BOKAREWA MI; FALK G; STENLINDER M; EGBERG N; BLOMBACK M; BREMME K
Article: BLOOD COAGULATION & FIBRINOLYSIS. 1995;6(5):417-422
PHOSPHOLIPID ANTIBODIES AND RESISTANCE TO ACTIVATED PROTEIN-C IN WOMEN WITH THROMBOPHILIA
BOKAREWA MI; BLOMBACK M; BREMME K
Article: THROMBOSIS RESEARCH. 1995;78(3):193-200
STUDIES ON PHOSPHOLIPID ANTIBODIES, APC-RESISTANCE AND ASSOCIATED MUTATION IN THE COAGULATION-FACTOR-V GENE
BOKAREWA MI; BREMME K; FALK G; STENLINDER M; EGBERG N; BLOMBACK M
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 1995;132(4):438-443
MIDMOLECULAR PARATHYROID HORMONE-RELATED PEPTIDE IN SERUM DURING PREGNANCY, LACTATION AND IN UMBILICAL-CORD BLOOD
BUCHT E; RONG HQ; BREMME K; GRANBERG B; RIAN E; TORRING O
Article: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 1995;39(4):234-238
INCREASED CONCENTRATIONS OF LACTATE-DEHYDROGENASE IN PREGNANCY WITH PREECLAMPSIA - A PREDICTOR FOR THE BIRTH OF SMALL-FOR-GESTATIONAL-AGE INFANTS
HE S; BREMME K; KALLNER A; BLOMBACK M
Visa fler

Alla övriga publikationer

Letter: THROMBOSIS RESEARCH. 2018;172:51-53
Increasing thrombin generation during IVF treatment is correlated to hormonal changes, but not to TFPI
Bremme K; Soutari N; Antovic JP; Wramsby M; Chaireti R
Letter: THROMBOSIS RESEARCH. 2018;168:145-147
Risk factors and obstetric outcomes in pregnancies complicated by pelvic vein thrombosis, and in the subsequent pregnancy
Bremme K; Hinnerdal SL; Sjoquist SH; Chaireti R
Letter: JOURNAL OF HYPERTENSION. 2018;36(8):1770-1771
Cardiac function in pregnancy Reply
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Ostlund E; Kahan T
Review: LUPUS SCIENCE & MEDICINE. 2018;5(1):e000197
Obstetric antiphospholipid syndrome
Antovic A; Sennstrom M; Bremme K; Svenungsson E
Review: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2017;49(1):46-53
Longitudinal study of vascular structure and function during normal pregnancy
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Jorneskog G; Ostlund E; Kahan T
Letter: HYPERTENSION RESEARCH. 2015;38(11):796-797
Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsia
Kahan T; Bremme K; Ostlund E
Review: AUTOIMMUNITY REVIEWS. 2015;14(6):498-502
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study
Mekinian A; Lazzaroni MG; Kuzenko A; Alijotas-Reig J; Ruffatti A; Levy P; Canti V; Bremme K; Bezanahary H; Bertero T; Dhote R; Maurier F; Andreoli L; Benbara A; Tigazin A; Carbillon L; Nicaise-Roland P; Tincani A; Fain O
Letter: THROMBOSIS RESEARCH. 2011;127(6):605-606
Thromboxane metabolite excretion during pregnancy - influence of preeclampsia and aspirin treatment
Perneby C; Vahter M; Akesson A; Bremme K; Hjemdahl P
Published conference paper: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2010;203(5):469.e1-469.e8
Factor V Leiden mutation and pregnancy-related complications
Kjellberg U; van Rooijen M; Bremme K; Hellgren M
Corrigendum: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2006;194(5):1499
Sex hormone-binding globulin - A surrogate marker for the prothrombic effects of combined oral contraceptives (vol 190, pg 332, 2004)
van Roolien M; Silveira A; Hamsten A; Bremme K
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2004;2(5):838-839
Antithrombin antigen and activity in patients with acquired antithrombin deficiency -: is there a difference?
Ungerstedt JS; Antovic J; Blombäck M; Bremme K; Johnsson H
Review: BLOOD COAGULATION & FIBRINOLYSIS. 1999;10(3):127-132
Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?
He S; Bremme K; Blombäck M
Published conference paper: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 1996;12(1):31-36
The long-term outcome of proximal vein thrombosis during pregnancy is not improved by the addition of surgical thrombectomy to anticoagulant treatment
Torngren S; Hjertberg R; Rosfors S; Bremme K; Eriksson M; Swedenborg J

Examina och utbildning

Docent, 1986

Artiklar

Alla övriga publikationer

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI